Literature DB >> 19861391

Why, how and when do we need to optimize the setting of cardiac resynchronization therapy?

Matteo Bertini1, Victoria Delgado, Jeroen J Bax, Nico R L Van de Veire.   

Abstract

Current cardiac resynchronization therapy (CRT) devices allow manipulation of the atrioventricular (AV) and interventricular (VV) timings in order to maximize the left ventricular (LV) performance. Multiple echocardiographic and non-echocardiographic methods have been proposed to optimize AV and VV intervals but no consensus has been reached on which methodology should preferably be used. Furthermore, different physiologic conditions, such as rest and exercise, may markedly change LV loading conditions, and therefore an optimal setting determined at rest may be different during exercise. The present article reviews current methodologies to optimize AV and VV interval and discuss why, when and how optimization of these delays may be performed based on current evidence. Moreover, an overview of the results of the multicenter trials on AV and VV intervals optimization is provided.

Entities:  

Mesh:

Year:  2009        PMID: 19861391     DOI: 10.1093/europace/eup275

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  9 in total

Review 1.  Non-response to Cardiac Resynchronization Therapy.

Authors:  Syed Yaseen Naqvi; Anas Jawaid; Ilan Goldenberg; Valentina Kutyifa
Journal:  Curr Heart Fail Rep       Date:  2018-10

Review 2.  How to improve outcomes: should we put more emphasis on programming and medical care and less on patient selection?

Authors:  Laszlo Buga
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

3.  Impact of VV optimization in relation to left ventricular lead position: an acute haemodynamic study.

Authors:  Fakhar Z Khan; Munmohan S Virdee; Philip A Read; Peter J Pugh; David Begley; Simon P Fynn; David P Dutka
Journal:  Europace       Date:  2011-03-21       Impact factor: 5.214

4.  Effects of biventricular pacing on left heart twist and strain in a porcine model of right heart failure.

Authors:  Alice Wang; Santos E Cabreriza; Vinod Havalad; Linda Aponte-Patel; Gerardo Gonzalez; Bryan Velez de Villa; Bin Cheng; Henry M Spotnitz
Journal:  J Surg Res       Date:  2013-07-09       Impact factor: 2.192

5.  A novel methodology for AV and VV delay optimization in CRT: results from a randomized pilot clinical trial.

Authors:  Arianna Di Molfetta; Giovanni B Forleo; Luca Santini; Libera Fresiello; Lida P Papavasileiou; Giulia Magliano; Domenico Sergi; Ambrogio Capria; Francesco Romeo; Gianfranco Ferrari
Journal:  J Artif Organs       Date:  2013-03-16       Impact factor: 1.731

Review 6.  Atrioventricular and interventricular delay optimization in cardiac resynchronization therapy: physiological principles and overview of available methods.

Authors:  Patrick Houthuizen; Frank A L E Bracke; Berry M van Gelder
Journal:  Heart Fail Rev       Date:  2011-05       Impact factor: 4.214

7.  Potential benefit of optimizing atrioventricular & interventricular delays in patients with cardiac resynchronization therapy.

Authors:  Bozena Urbanek; Krzysztof Kaczmarek; Artur Klimczak; Jan Ruta; Michal Chudzik; Katarzyna Piestrzeniewicz; Pawel Ptaszynski; Jerzy Krzysztof Wranicz
Journal:  Indian J Med Res       Date:  2017-07       Impact factor: 2.375

Review 8.  Rationale and design of the AdaptResponse trial: a prospective randomized study of cardiac resynchronization therapy with preferential adaptive left ventricular-only pacing.

Authors:  Gerasimos Filippatos; David Birnie; Michael R Gold; Bart Gerritse; Ahmad Hersi; Sandra Jacobs; Kengo Kusano; Christophe Leclercq; Wilfried Mullens; Bruce L Wilkoff
Journal:  Eur J Heart Fail       Date:  2017-07       Impact factor: 15.534

9.  Cardiac resynchronization therapy; evaluation by advanced imaging techniques.

Authors:  E E van der Wall; M J Schalij; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2009-12-29       Impact factor: 2.357

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.